First Step Towards The Legalization Of CBD-Based Products

First Step Towards The Legalization Of CBD-Based Products

According to conservative estimates, the CBD industry is expected to reach $16 billion in the United States by 2025. The industry is flourishing because CBD users have taken it for anxiety, chronic pain, insomnia, and depression without undesirable side effects. The extract from the cannabis plant is now being manufactured as oils, edibles, lotions, and creams and more recently as roll-on sticks.

What is cannabis?

Cannabis is a group of 3 plants with psychoactive properties – cannabis sativa, cannabis Indica, and cannabis ruderalis. The flowers of the cannabis plants are harvested and dried and sold as marijuana, one of the most common drugs in the world that is heavily regulated.

Cannabis has more than 120 components known as cannabinoids but the most popular are cannabidiol (CBD) and tetrahydrocannabinol (THC). The more famous component is THC because it provides the user with a feeling of euphoria or “high.” The lesser-known component is CBD that is non-psychoactive and is presumed to provide numerous health benefits without the “high.”

CBD is often used to reduce inflammation and pain and ease nausea, migraine, seizures, and anxiety. Epidiolex is the first CBD-based prescription medicine that has been approved by the Food and Drug Administration to treat certain kinds of epilepsy. In September 2017, the US Drug Enforcement Agency has removed CBD from the most restrictive class of controlled substances. The agency has allowed the sale of the first non-synthetic, cannabis-derived medicine, an admission that the plant has medicinal value.

The DEA has also announced that drugs with CBD and THC content below 1% have been categorized under Schedule 5 as long they have been approved by the DFA. According to James Minutello, CEO of Leaf Logix in Glendale California, they are one step closer to ending prohibitions and legalizing the CBD industry.

Cannabis sativa is an herbaceous species grown in Central Asia. People use it as folk medicine and a source of textile fibre since the ancient times. The resurgence of interest on cannabis is due to its multi-purpose applications in human health. The use of sustainable sources like natural plants is being pushed to reduce dependence on opioids that are prescribed for serious chronic pain. The focus is now on cannabis sativa because it is a source of fibres, oils, and molecules with a variety of phytochemicals.

Now that cannabidiol is readily available in many states, people are confused about whether it comes from the hemp or marijuana plant. CBD, an active ingredient of medical marijuana, is derived from hemp plant. CBD is not the marijuana that causes euphoria. According to the World Health Organization, CBD exhibits no effects on humans that indicate drug abuse or potential dependence. There are also no evidences of health problems among the users of CBD products.

One of the recent CBD-products in the market is CBD roll-on sticks for people with an active lifestyle. The roll-on sticks contain organic hemp which means that you can expect the best results from the product. There are no unpleasant side effects because chemicals have not been used to spoil its efficacy.